$16.9 million for cutting edge medical innovations | Health and Aged Care Portfolio Ministers – Australian Government Department of Health

Ministers Department of Health and Aged Care
Fifteen cutting edge medical research and technology projects will receive a total of $16.9 million from the Australian Government to accelerate their transition into clinical practice.
The Hon Mark Butler MP
Minister for Health and Aged Care
Fifteen cutting edge medical research and technology projects will receive a total of $16.9 million from the Australian Government to accelerate their transition into clinical practice.
The projects all have tremendous potential to transform the lives of people here and around the world.
Nine of the projects will receive a total of $6.7 million from the Medical Research Future Fund (MRFF) Targeted Translation Research Accelerator (TTRA) program. All of these projects target aspects of diabetes and cardiovascular disease, which are leading causes of death and disability.
They include development of a new external controller for an artificial heart which could allow patients with heart failure to recover and lead normal lives without requiring a transplant, and a clinical trial of the use of genetically engineered islet cells to restore glucose control in people with type 1 diabetes.
Five projects will receive $7.2 million through the Clinical Translation and Commercialisation Medtech (CTCM) Program under the MRFF Medical Research Commercialisation initiative. They are developing a diverse range of new medical technology, including a ‘next generation’ condom and a wearable device that restores vision to some blind and vision-disabled people.
The great promise of these projects is reflected in the private co-funding they have attracted, totalling $8.6 million for the TTRA projects and $12.9 million for the CTCM projects. Their connections with translation partner companies have been supported by MTPConnect, which delivers the grants programs for the Government.
Today the Government also highlights $3 million in recently awarded funding for researchers from Sydney Children’s Hospital Network (SCHN), the University of Sydney, NSW Health Pathology and the CSIRO to explore how genome sequencing could be used to rapidly target diseases or genetic conditions with available therapies.
This project, called NEWBORN GEN SEQ TRAIL (Newborn Genomic Sequencing in screening: Therapy Ready And Information for Life) will be led by Clinical Professor Bruce Bennetts, Department Head of Molecular Genetics at SCHN.
Quotes attributable to Minister Butler:
“These promising projects show once again that Australian medical researchers are among the best in the world.
“With funding from the Government and support from research translation partners, they are all poised to progress along the road to becoming part of next generation medicine.
“Every Australian can be proud of the contribution these research teams are making to changing the outlook for patients with life-changing health issues.”
Targeted translation research accelerator (round 2) research projects:
Project
Institution
Funding
Development of the BiVACOR total artificial heart controller for long-term use
BiVACOR Pty Ltd (Queensland)
$750,000
Getting to the Heart of It: Improving Heart Failure Outcomes with the Smart-HF program
Cardihab Pty Ltd (Queensland)
$740,153
A hospital-based point of care monitor to provide earlier detection and treatment of stroke to prevent long term disability and death
Cyban Pty Ltd (Victoria)
$700,000
HypoPAST: Online psycho-educational training for ‘Hypoglycaemia Prevention, Awareness of Symptoms, and Treatment’ in adults with type 1 diabetes 
Deakin University (Victoria)
$749,764
Restoring glucose control in T1D patients with genetically engineered GARV-AAV2-A20-islet cells – a first in Human safety and efficacy trial 
Garvan Institute of Medical Research (NSW)
$749,979
Improved glucose control, with lower insulin doses, for the treatment of type 1 diabetes 
Monash University (Victoria)
$750,000
Bringing oral quantum dot insulin to phase I clinical studies 
University of Sydney (NSW)
$750,000
Small molecule inhibitors of the P2X7 receptor as a safe and effective way of tackling the inflammatory contribution to atherosclerosis 
University of Sydney (NSW)
$749,536
The APHLID-M project: Apps and Peer support for a Healthy future and Living Well with Diabetes Project 
Western Sydney University (NSW)
$744,873
Clinical Translation and Commercialisation Medtech (CTCM) Program Projects
Project
Institution
Funding
Clinical trial and pilot of ARIA Non-Invasive Bionic Vision System
ARIA Research Pty. Ltd (NSW)
$1,500,000
Clinical Trial of the Next Generation Condom
Eudaemon Technologies Pty Ltd (NSW)
$1,500,000
APAS Compact – Development of a desktop device for automated microbiology culture plate reading and reporting
LBT Innovations Ltd (SA)
$1,500,000
Safer care for critically-ill children: clinical translation of a new medical device to place and monitor paediatric central vascular catheters 
Navi Medical Technologies Pty. Ltd (Vic)
$1,239,187
Commercialisation of a diagnostic imaging system for cancer surgery
OncoRes Medical, (WA)
$1,500,000
2021 Genomics Health Futures Mission Projects
Project
Institution
Funding
NEWBORN GEN SEQ TRAIL: NEWBORN GENomicSEQuencing in screening: TherapyReadyAndInformation forLife
University of Sydney
$2,992,976.00
Is there anything wrong with this page?
If you would like a response please use the enquiries form instead.
We are always looking for ways to improve our website.
The Department of Health and Aged Care acknowledges the traditional owners of country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to elders both past and present.
© Commonwealth of Australia | Department of Health and Aged Care

source